PANOME BIO INC
SAINT LOUIS, MO · Founded 2022 · CIK 0001966691 · Biotech · Private
Multi-omics analysis platform providing metabolomics, proteomics, and transcriptomics services
panomebio.com →- Grants
- $882K
- 1 award
- Sector median: 1
- Raised
- $12M
- 2 Form D · Nov 2024
- 22 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $5,973,835 | |
| Private capital raised | Form D · SEC | $6,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Biomarker discovery in colon cancer through next-generation metabolomics | $881,647 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2484 | Incannex Healthcare Inc. | — | $12M |
| 2485 | Genialis, Inc. | — | $12M |
| 2486 | Borealis Biosciences | — | — |
| 2487 | PANOME BIO INC | — | $12M |
| 2488 | ANAVEX LIFE SCIENCES CORP. | — | $11M |
| 2489 | APPLIED GENETIC TECHNOLOGIES CORPORATION | — | $9.3M |
| 2490 | 3+2 PHARMA, LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Rob CaponeDirector
- Tom CohenExecutive Officer
- Alexander HerzickDirector
- Deval LashkariDirector
- David SmollerDirector
- Edward WeinsteinDirector · Executive Officer
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.